- According to a filing by the U.S. Securities and Exchange Commission, Intel CEO Pat Gelsinger purchased 105,263 shares of Intel stock on the open market at an average price of $95 per share on August 11.
- Soros Fund Management disclosed an increase of 29,004 shares in Apple (AAPL.US), raising its holdings to 529,538 shares.
- Riot Platforms unit secures USD 573 million delayed-draw term loan facility for Rockdale data center project
- Matson SVP Jason Lee Taylor sells 1,961 common shares for $425,537
- Aeternum Health delays filing quarterly report for period ended June 30, 2026
- MDWerks delays quarterly 10-Q filing as June 30 financial statements remain unfinished
- Celldex posts investor presentation highlighting barzolvolimab late-stage chronic urticaria program milestones
- Cullinan Therapeutics CSO Jennifer Michaelson disposes of 30,000 common shares worth $607,800
- Allied Tecnologia selling shareholders cut stake to 29.01% after 11,111,117-share sale to Radomysler family
- Paysign CFO Jeffery Bradford Baker disposes of 35,000 shares worth $441,637
- KinderCare Education signs amended master lease covering 545 center sites with KCP RE
- Columbus Circle Capital II delays Q2 10-Q filing, cites need to finalize financial statements
- Actinium Pharma says two US Actimab-A patents issued for solid tumor treatment through 2043
- Carvana enters $1.66 billion senior secured term loan B credit agreement with Barclays agent
- Multiplan board authorizes management to proceed with annual business plan implementation
- Neural Therapeutics wins CSE conditional approval for Hanf.com acquisition deal
- Western Exploration grants 1,300,000 stock options at $0.78 per share under equity incentive plan
- Appili net loss widens 100% to CAD 1 million in Q3 FY26
- Crombie REIT declares $0.08 per unit August distribution
- Sun Life defers redemption of preferred shares due Sept. 30, 2026, opens conversion option
- Aurora Spine settles SI joint patent royalty arbitration with SILIF for $283,000
- Clairvest 4Q Net C$48.4M >CVG.T
- Clairvest 4Q EPS C$3.61 >CVG.T
- HealthLynked Q2 FY26 net loss widens 17% to USD 819,705; revenue drops 58% to USD 249,830
- Outdoor Holding Company announces annual shareholder meeting
- Standard Lithium launches US$50 million at-the-market equity program
- Vivakor delays Q2 10-Q filing after financial statement preparation setback
- Riskified Chief Strategy Officer Assaf Feldman disposes of 656,096 shares for USD 4.06 million
- Largo Q2 2026 loss widens as higher production costs outweigh 68% revenue jump, company says
- Ranger Gold delays quarterly report filing for period ended June 30, 2026
- Maze Therapeutics President, R&D and CMO Harold Bernstein disposes of USD 445,522 common shares
- Edgewise Therapeutics CMO Joanne M. Donovan disposes of USD 411,192 in common shares
- AZZ Metal Coatings COO Bryan Lee Stovall sells 2,677 shares for $401,727.68
- 3M files Form 3 initial beneficial ownership statement for EVP, Chief HR Officer Jennifer Cunningham
- Bicara Therapeutics CFO Jennifer Larson files initial beneficial ownership statement
- Planet Ventures CEO Moshevich discloses 11.87% stake after rights transfer
- According to a document from the US Securities and Exchange Commission, AMD (AMD.US) holds 3.3 million Class A shares of SpaceX (SPCX.US).
- CenterPoint Energy unit Energy Systems Group wins 2026 Great Place to Work certification
- Optimi Health sets US$100 million equity line of credit with Seven Knots
- Silence Therapeutics closes upsized $201.3 million ADS follow-on offering at $13.5 each
- Park Aerospace Chairman and CEO Brian Shore disposes of 80,000 common shares worth $3.05 million
- Liminatus Pharma Q2 FY26 net loss widens to $1.41 million; operating loss widens 23% to $1.38 million
- Warner Bros Discovery Director Richard W. Fisher sells 20,000 shares for $549,200
- CarGurus director Greg M. Schwartz disposes of Class A shares worth $360,700
- Polpar 1H FY26 profit drops 74.62% to R$ 33,000
- OFG Bancorp director Nestor De Jesus sells 4,000 common shares for $212,000
- Starfighters Space delays Q2 Form 10-Q filing, cites missing business information
- Sow Good delays Q2 Form 10-Q filing, targets Aug. 19 submission
- BiomX delays Q2 10-Q filing, cites accounting staff absence and acquisition accounting review
- Braze CTO Jonathan Hyman sells 35,000 shares for $1.05 million
- Crane director James L. L. Tullis sells 614 shares for $138,150
- Ton Strategy CEO Kevin Mark Wilson reports $19,509 common share purchase
- PSB Financial Q2 FY26 turns to net loss of $148,000; net interest income rises 3.2% to $931,000
- PetVivo FY27 Q1 net loss narrows to $1.61 million; revenue rises 13.47% to $337,572
- Scilex Q2 FY26 net loss widens to $114.99 million; revenue falls 22.78% to $7.64 million
- Lightstone Value Plus REIT III returns to profit in Q2 FY26; revenue rises to $8.1 million
- Curbline Properties director Alexander Otto sells USD 6.98 million in common shares
- US Foods officer Randy J. Taylor disposes of 11,630 common shares valued at $1.28 million
- Carriage Services CIO Rob Franch resigns effective immediately
- Innoviz Technologies announces annual shareholder meeting
- Stemtech Q2 FY26 net loss narrows 1.32% to $292,358; net sales fall 9.8% to $629,312
- Cboe director Janet P. Froetscher disposes of 937 common shares worth $261,576.15
- Teads gets Nasdaq notice after shares trade below $1 for 30 straight sessions
- Target signs $4 billion five-year revolving credit facility with bank group
- Sophia Genetics CSO Zhenyu Xu sells 4,000 shares for USD 30,076.4
- Western Uranium Q2 FY26 net loss narrows 40.98% to $1.16 million; revenue rises to $199,528
- Jupiter Neurosciences FY26 Q2 net loss widens 0.95% to $2.27 million; revenue totals $24,245
- Lightstone Value Plus REIT II Q2 FY26 swings to net income of $209,000; revenue rises 4.51% to $13.9 million
- OneMedNet Q2 FY26 operating loss widens 10% to 2.26 million; revenue rises 88% to 292,000
- United Therapeutics CEO Chair Martine Rothblatt disposes of 9,500 shares for $4.81 million
- Abacus Global CEO Jay J. Jackson disposes of 196,000 shares for $1.72 million
- Venture Global Director Jimmy D. Staton sells USD 881,034 of common shares
- Sidus Space 2Q Rev $583,096 >SIDU
- Ares Capital holds special shareholder meeting on stock issuance proposal
- Dave Inc.: Yadin Rozov Resigns From Bd. >DAVE
- BRIEF-Laser Photonics Q2 EPS USD -0.08
- Monroe Federal Bancorp Q1 FY27 net loss narrows to $1,500; net interest income rises 8.4% to $983,000
- Lionheart Holdings Q2 FY26 net loss widens to $4.62 million; operating costs jump to $6.82 million
- Laser Photonics Q2 FY26 net loss widens 85% to $3.28 million; net sales fall 30% to $1.81 million
- 374Water announces annual shareholder meeting
- Vynleads net loss widens to USD 63,889 in Q2 FY26; revenue stays at no revenue
- BRIEF-Starboard Cuts Stake In News Corp, Match Group
- Dow Jones Stock Averages Closing Ranges
- S&P 500 Logs Third-Consecutive Weekly Gain -- WSJ
- Bio Essence swings to Q2 FY26 profit of $270,077; revenue more than doubles to $794,711
- Alarm.com CFO Kevin Christopher Bradley reports disposal of 5,400 common shares worth $297,378
- Patterson-UTI reports 98 average US drilling rigs operating in July 2026
- Talon Capital swings to Q2 FY26 net income of $1.32 million
- Cboe Global Markets files Form 3 for EVP, Chief Risk Officer Boudewijn Duinstra
- PubMatic Chief Accounting Officer Lisa Gimbel sells 500 shares worth $8,750
- Apollo Global Management files Form 3 initial beneficial ownership statement for LDB 2025 LLC
- GD Culture Group Q2 FY26 net loss more than doubled to $52.2 million; operating loss widens 83.2% to $2.85 million
- Iveda Q2 FY26 net loss narrows to USD 793,469; revenue falls 48% to USD 801,846
- Alaunos net loss narrows to $1.9 million in Q2 2026; revenue posts no revenue in H1 2026
- Silicon Valley Acquisition net income rises to $1.14 million in Q2 FY26
- Cyberloq delays Q2 10-Q filing after auditor review runs late
- Two Hands delays quarterly filing for period ended June 30, 2026
- Greenlane Holdings 2Q Loss/Shr $6.06 >GNLN
- Cue Biopharma 2Q Loss/Shr $24.14 >CUE
- Cue Biopharma 2Q Loss $153.1M >CUE
